1-Bromo-2-fluoro-4-isopropylbenzene, 98%, 1g

(6R)-3-[(2-chlorophenyl)sulfanyl]-6-[4-(morpholin-4-yl)phenyl]-6-(thiophen-3-yl)piperidine-2,4-dione, 98%, 5mg

(1Z,2Z)-Cyclohexane-1,2-dione dioxime, 97.0%, 5g

5-Etinil-2-deossiuridina (EdU), minimo 98%, 5 mg, confezione in plastica.

2,3-Difluoro-4-[(trans-4-propylcyclohexyl)methoxy]anisole>98.0%(GC)1g

1-Chloroethyl 2,4-dichloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate, 95.0%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-3-yl)propanoic acid, 95.0%, 10g

(4-Chlorophenyl)(2-nitrophenyl)sulfane, 98%, 100mg

Methyl 1-(2-methoxy-2-oxoethyl)-1h-pyrazole-4-carboxylate, 97%, 500mg

4-Chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole [Bifunctional Fluorescent Reagent]>97.0%(T)1g

5-Bromo-1,3-benzenedithiol>98.0%(GC)1g

1H,1H,5H-Octafluoropentyl Methacrylate (stabilized with MEHQ)>98.0%(GC)5g

PARAXANTHINE, 95%, 1g